Liquidia shares climbed 7.5% after disclosing that it is scheduled to make its first commercial shipment of Yutrepia inhalation powder, days after Food and Drug Administration approval. Shares were ...

Like other inhaled prostaglandins, YUTREPIA may cause acute bronchospasm. Patients with asthma or chronic obstructive pulmonary disease (COPD), or other bronchial hyperreactivity, are at increased ...

The US Food and Drug Administration (FDA) has approved treprostinil inhalation powder (YUTREPIA), a prostacyclin analog ...

The FDA has approved a novel inhalation powder for pulmonary arterial hypertension and interstitial lung disease-associated ...

On Friday, the U.S. Food and Drug Administration (FDA) approved Liquidia Corporation's LQDA Yutrepia (treprostinil) ...

Report Ocean has published a new report on the Saudi Arabia Pharmaceutical Drug Delivery Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities.

Pursuant to that strategy, we remain on track to complete the technology transfer with our second-source drug substance contract ... trade name for molgramostim inhalation solution.

TUESDAY, June 3, 2025 (HealthDay News) — A new study has found a super-sweet chemical in illegal flavored e-cigarettes that ...

received US Food and Drug Administration (FDA) approval for manufacturing and distributing generic Albuterol Sulfate Inhalation Solution, 0.5% (2.5 mg/0.5 mL)* "Driven by the needs of escalating ...

Xenoview is a hyperpolarized xenon inhaled contrast agent indicated for use with magnetic resonance imaging for evaluation of lung ventilation.

The Environmental Working Group published its Annual Guide to Sunscreens, finding that less than one in four SPF products are fully safe and effective.

Contributor content. Whether you’re a cannabis newbie or a pro, cannabis-infused gummies might be a smoke-free option for ...